Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: Direct assessment of resistance to reverse transcriptase inhibitors in vivo

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 628-634

  Zhang, Hui ^a   Dornadula, Geethanjali ^a   Wu, Yong ^a   Havlir, Diane ^b   Richman, Douglas D ^b,c   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS GENOME; VIRUS PARTICLE;

BASE SEQUENCE; COHORT STUDIES; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HUMAN; KINETICS; LONGITUDINAL STUDIES; MOLECULAR SEQUENCE DATA; MUTATION; NEVIRAPINE; PYRIDINES; REVERSE TRANSCRIPTASE INHIBITORS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; VIRION;

EID: 0029655647     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.628-634.1996     Document Type: Article

References (29)

1. Arner, E. S., A. Valentin, and S. Eriksson. 1992. Thymidine and 3′-azido-3′-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. J. Biol. Chem. 267:10968-10975.
2. Bagnarelli, P., S. Menzo, A. Valenza, A. Manzin, M. Giacca, F. Ancarani, G. Scalise, P. E. Varaldo, and M. Clementi. 1992 Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J. Virol. 66:7328-7335.
3. Cheeseman, S. H., D. Havlir, M. M. McLaughlin, T. C. Greenough, J. L. Sullivan, D. Hall, S. E. Hattox, S. A. Spector, D. S. Stein, M. Myers, and D. D. Richman. 1995. Phase III evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquired Immune Defic, Syndr. 8:141-151.
4. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
5. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. Van Dyke, M. Bey, W. Shearer, R. L. Jacobson, E. Jimenez, E. O'Neill, B. Bazin, J.-F. Delfraissy, M. Culnane, R. Coombs, M. Elkins, J. Moye, P. Stratton, and J. Balsley. For the pediatric AIDS clinical trials group protocol 076 study group. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Engl. J. Med. 331:1173-1180.
6. Gao, W., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes, a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad Sci. USA 90:8925-8928.
7. Havlir, D., S. H. Cheeseman, M. McLaughlin, R. Murphy, A. Erice, S. A. Spector, T. C. Greenough, J. L. Sullivan, D. Hall, M. Myers, M. Lamson, and D. D. Richman. 1995. High-dose nevirapinc: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J. Infect. Dis 171:537-545.
8. Henrard, D. R., W. F. Mehaffey, and J. P. Allain. 1992. A sensitive viral capture assay for detection of plasma viremia in HIV-infected individuals. AIDS Res. Hum. Retroviruses 8:47-52.
9. Ho, D. D., T. Moudgil, and M. Alam. 1989 Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:621-625.
10. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
11. Holodniy, M., D. A. Katzenstein, D. M. Israelski, and T. C. Merigan. 1991. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction. J. Clin. Invest 88:1755-1759.
12. Kohlstaedt, L. A., J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1992 Crystal structure at 3 5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
13. Koup, R. A., and D. D. Ho. 1990. Quantitative culture assay for HIV-1 in peripheral blood. In A Aldovini and B. D. Walker (ed.) Techniques in HIV research, p. 107-112. Stockton Press, New York.
14. Lori, F., F. M. Veronese, A. L. DeVico, P. Lusso, M. S. Reitz, and R. C. Gallo. 1992. Viral DNA carried by HIV-I virions. J Virol 66:5067-5074.
15. Merluzzi, V. J., K. D. Hargrave, M. Labadia, K. Grozinger, M. Skoog, J. C. Wu, C.-K. Shih, K. Eckner, S. Hattox, J. Adams. A. S. Rosehthal, R. Faanes, R. J. Eckner, R. A. Koup, and J. L. Sullivan. 1990. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250: 1411-1413
16. Moses, A. V., F. E. Bloom, C. D. Pauza, and J. A. Nelson. 1993. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism Proc Natl. Acad. Sci. USA 90:10474-10478.
17. Qian, M., T. Bui, R. J. Ho, and J. D. Unakat. 1994. Metabolism of 3′-azido3′-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells. Biochem. Pharmacol. 48:383-389.
18. Richman, D. D. 1994. Viral resistance to antiretroviral therapy In S. Broder, T. C. Merigan, and D. Bolognesi (ed.), Textbook of AIDS medicine, p 795-805. Williams & Wilkins, Baltimore.
19. Richman, D. D., D. Havlir, J. Corbeil, D. Looney, C. Ignancio, S. A. Spector, J. Sullivan, S. Cheeseman, K. Baringer, D. Pauletti, C.-K. Shih, M. Myers, and J. Griffin. 1994. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J. Virol. 68:1660-1666
20. Richman, D. D., C.-K. Shih, I. Lowy, J. Rose, P. Prodanovich, S. Goff, and J. Griffin. 1991. Human immunodeficiency virus type 1 mutants resistant to non-nucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl. Acad Sci USA 88:11241-11245.
21. Spence, R. A., W. M. Kati, K. S. Anderson, and K. A. Johnson. 1995. Mechanisms of inhibition of HIV-1 reverse transcriptase by non-nucleoxide inhibitors. Science 267:988-993.
22. Tornevik, Y., B. Jacobsson, S. Britton, and S. Eriksson. 1991 Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res. Hum Retroviruses 7:751-759.
23. Trono, D. 1992. Partial reverse transcripts in virions from HIV and MLV J. Virol. 66:4893-4900.
24. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
25. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction J. Virol. 31:2960-2966
26. Zhang, H., O. Bagasra, M. Niikura, B. J. Poiesz, and R. J. Pomerantz. 1994. Intravirion reverse transcripts in the peripheral blood plasma of HIV-1-infected individuals. J. Virol. 68:7591-7597.
27. Zhang, H., G. Dornadula, M. Niikura, O. Bagasra, B. J. Poiesz, and R. J. Pomerantz. 1995. Natural endogenous reverse transcription (NERT) of human immunodeficiency virus type 1 (HIV-1). J. Cell. Biochem. Suppl 21B: 200. (Abstract.)
28. Zhang, H., L. Duan, G. Dornadula, and R. J. Pomerantz. 1995 Increasing transduction efficiency of recombinant murine retroviral vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies J. Virol. 69:3929-3932.
29. Zhang, H., Y. Zhang, T. P. Spicer, L. Z. Abbott, M. Abbott, and B. J. Poiesz. 1993 Reverse transcription takes place within extracellular HIV-1 virions: Potential biological significance. AIDS Res. Hum. Retroviruses 9:1287-1296.